Claybrook Capital’s Qiagen QGEN Stock Holding History

Claybrook Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25	Closed	-$1K	–	542
2018 Q4	$1K	Buy	+25	New	+$928	﹤0.01%	728

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Claybrook Capital's QGEN Position: Q1 2019 in Review

Claybrook Capital sold out of Qiagen (QGEN) in Q1 2019, closing a stake of 25 shares — an estimated $1K sold.

Claybrook Capital first reported a position in QGEN in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 262 funds tracked by Wall St. Rank hold QGEN as of Q1 2019.

Claybrook Capital reported no remaining Qiagen position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 25 Qiagen shares in Q1 2019, an estimated $1K.
Claybrook Capital first reported a position in Qiagen in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Qiagen position peaked at $1K in Q4 2018.
262 funds tracked by Wall St. Rank held Qiagen as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.